文献速递主动脉疾病

胸主动脉瘤现行管理实践与女性症状性表现增加相关

Current management practices for thoracic aortic aneurysms are associated with increased symptomatic presentation in females.
PubMed 文献 · J Vasc Surg · 2025-08-05

基于血管质量倡议(VQI)2013至2023年数据,纳入2383例接受TEVAR的降胸主动脉瘤患者,女性症状性或破裂表现更常见(35.9% vs 29.1%,P < .005),体表面积校正的主动脉尺寸指数(ASI)独立预测症状性表现或破裂(OR 1.3,95%CI 1.2-1.5),但干预时中位尺寸趋势未显著变化。

要点

  • 女性TEVAR患者症状性或破裂表现比例显著高于男性(35.9% vs 29.1%)。
  • 体表面积校正的ASI在女性中更大,且独立预测症状性表现或破裂(OR 1.3)。
  • 继续依赖最大主动脉直径作为干预标准可能使女性处于不良表现风险中。

核心结论

  • 女性降胸主动脉瘤患者接受TEVAR时更常表现为症状性或破裂,体表面积校正的ASI更大且独立预测不良表现。
  • 尽管ASI在女性中更大,干预时中位尺寸趋势未显著变化,提示依赖最大直径的干预标准可能使女性风险增加。

研究设计与样本

  • 回顾性队列研究,查询血管质量倡议(VQI)2013至2023年数据,纳入2383例因降胸主动脉瘤接受TEVAR的患者(女性1183例,男性1200例)。
  • 次要分析纳入动脉瘤尺寸小于55 mm的702例患者(女性357例,男性345例)。

主要发现

  • 女性总体症状性或破裂表现比例为35.9%,男性为29.1%(P < .005),小动脉瘤队列中亦见类似关联。
  • 男性体表面积更大(2.0 vs 1.7,P < .005),但体表面积校正的ASI在女性中显著更大,尽管未校正的动脉瘤直径相似。
  • 体表面积校正的ASI是症状性表现或破裂的独立预测因子(OR 1.3,95%CI 1.2-1.5)。
  • 整个研究期间女性体表面积校正的ASI均大于男性。

临床怎么用

  • 在评估降胸主动脉瘤干预指征时,应考虑体表面积校正的ASI,而非仅依赖最大主动脉直径,以识别女性患者的不良表现风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Sex-specific differences exist in the natural history and clinical outcomes associated with aortic aneurysms. This study evaluated contemporary outcomes associated with thoracic endovascular aneurysm repair (TEVAR) for descending thoracic aortic aneurysms and analyzed management paradigm trends over a 10-year period. METHODS: The Vascular Quality Initiative was queried from 2013 to 2023 for all patients undergoing TEVAR for descending thoracic aortic aneurysm. A secondary analysis was performed for patients who underwent TEVAR with aneurysm size of less than 55 mm. The primary outcome studied was symptomatic presentation and/or rupture. Aneurysm size, adjusted using aortic size indices, before intervention was analyzed over the study period. RESULTS: We included 2383 patients, including 1183 females and 1200 males, in this study. The small aneurysm cohort included 702 patients with 357 female and 345 male patients. Documented cardiovascular comorbidities including hypertension, heart failure, end-stage renal disease, and cerebrovascular diseases were similar between males and females. Body surface area (BSA) was greater in males overall (2.0 vs 1.7; P < .005). Symptomatic or ruptured aneurysm presentation was more common in females overall (35.9% vs 29.1%; P < .005) and a similar association was seen in the small aneurysm cohort. The BSA-adjusted aortic size index (ASI) was significantly larger in females compared with males despite similar un-normalized aortic aneurysm diameters. BSA-adjusted ASI was an independent predictor of symptomatic presentation or rupture (odds ratio, 1.3; 95% confidence interval, 1.2-1.5). The BSA-adjusted ASI was greater for females than males across the entire study period. CONCLUSIONS: Female patients undergoing TEVAR for DTAAs were much more likely than male patients to present with symptomatic aneurysms or with aneurysm rupture. BSA-adjusted ASI was greater in females than males and independently predicted symptomatic or rupture presentation. Despite this finding, trends in median size at time of intervention have not changed significantly. Females remain at an increased risk of adverse presentation owing to continued reliance on maximum aortic diameter as the primary intervention criterion.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Jiang DJ, Pugar JA, Babrowski TA, et al. Current management practices for thoracic aortic aneurysms are associated with increased symptomatic presentation in females. J Vasc Surg. 2025. PMID: 40754235. doi:10.1016/j.jvs.2025.07.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。